Yidong Chen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

Science advances

University of Texas Health Science Center at San Antonio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center at San Antonio Sep 05 2008

United States

Professor :: Department of Epidemiology and Biostatistics

Publications

Khaled Mohamed Nassar, Xue Yang, Adriana Baker, Rahul Gopalam, William C Arnold, Timilehin T Adeniran, Marian H Hernandez Fernandez, Megharani Mahajan, Zhao Lai, Yidong Chen, Gangadhara R Sareddy, Suryavathi Viswanadhapalli, Lu-Zhe Sun, Ratna K Vadlamudi, Uday P Pratap
PELP1 is a novel therapeutic target in hepatocellular carcinoma. Cancer research communications (2024)
Frank J Penedo, Patricia I Moreno, Magela Pons, Paulo S Pinheiro, Michael H Antoni, Gilberto de Lima Lopes, Carmen J Calfa, Patricia Chalela, Luz M Garcini, Chen-Pin Wang, Yidong Chen, Adolfo Enrique Diaz Duque, Steven W Cole, Amelie G Ramirez
Avanzando Caminos (Leading Pathways): design and procedures of the Hispanic/Latino Cancer Survivorship Study. American journal of epidemiology 193 (7) (2024)
Frank J Penedo, Patricia I Moreno, Magela Pons, Paulo S Pinheiro, Michael H Antoni, Gilberto de Lima Lopes, Carmen J Calfa, Patricia Chalela, Luz M Garcini, Chen-Pin Wang, Yidong Chen, Adolfo Enrique Diaz Duque, Steven W Cole, Amelie G Ramirez
Avanzando Caminos (Leading Pathways): design and procedures of the Hispanic/Latino Cancer Survivorship Study. American journal of epidemiology 193 (7) (2024)
Uday P Pratap, Michael Tidwell, Henriette U Balinda, Nicholas A Clanton, Xue Yang, Suryavathi Viswanadhapalli, Gangadhara R Sareddy, Dong Liang, Huan Xie, Yidong Chen, Zhao Lai, Rajeshwar R Tekmal, Stanton F McHardy, Andrew J Brenner, Ratna K Vadlamudi
Preclinical development of brain permeable ERβ agonist for the treatment of glioblastoma. Molecular cancer therapeutics (2023)
William James Kelly, Adolfo Enrique Diaz Duque, Joel E Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair Kunnuparampil, John Floyd, Andrew J Brenner
Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
William James Kelly, Adolfo Enrique Diaz Duque, Joel E Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair Kunnuparampil, John Floyd, Andrew J Brenner
Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
William James Kelly, Adolfo Enrique Diaz Duque, Joel E Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair Kunnuparampil, John Floyd, Andrew J Brenner
Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu, Junhao Liu, Uday P Pratap, Behnam Ebrahimi, John R Sanchez, Xiaonan Li, Shihong Ma, Ben Ho Park, Bindu Santhamma, Yidong Chen, Zhao Lai, Ganesh V Raj, Yaxia Yuan, Daohong Zhou, Gangadhara R Sareddy, Rajeshwar R Tekmal, Stanton F McHardy, Tim Hui-Ming Huang, Manjeet K Rao, Hariprasad Vankayalapati, Ratna K Vadlamudi
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer. Cancer research 82 (20) (2022)
Pooja Yadav, Panneerdoss Subbarayalu, Daisy M Medina, Saif Nirzhor, Santosh Timilsina, Subapriya Rajamanickam, Vijay K Eedunuri, Yogesh K Gupta, Siyuan Zheng, Nourhan Abdelfattah, Yufei Huang, Ratna K Vadlamudi, Robert Hromas, Paul S Meltzer, Peter Houghton, Yidong Chen, Manjeet K Rao
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression. Cancer research 82 (10) (2022)
Natalia Garcia, Vanessa Del Pozo, Marielle E Yohe, Craig M Goodwin, Terry J Shackleford, Long Wang, Kunal Baxi, Yidong Chen, Anna T Rogojina, Sara M Zimmerman, Cody J Peer, William Douglas Figg, Myron S Ignatius, Kris C Wood, Peter J Houghton, Angelina V Vaseva
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma. Molecular cancer therapeutics (2021)
Yu-Chiao Chiu, Siyuan Zheng, Li-Ju Wang, Brian S Iskra, Manjeet K Rao, Peter J Houghton, Yufei Huang, Yidong Chen
Predicting and characterizing a cancer dependency map of tumors with deep learning. Science advances 7 (34) (2021)
Marieke Burleson, Janice J Deng, Tai Qin, Thu Minh Duong, Yuqian Yan, Xiang Gu, Debodipta Das, Acarizia Easley, Michael A Liss, P Renee Yew, Roble Bedolla, Addanki Pratap Kumar, Tim Hui-Ming Huang, Yi Zou, Yidong Chen, Chun-Liang Chen, Zhenlin Huang, Lu-Zhe Sun, Thomas G Boyer
GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer. Molecular cancer research : MCR (2021)
Li She, Hamad H Alanazi, Liping Yan, Yi Zou, Yilun Sun, Peter H Dube, Edward G Brooks, Gema D Barrera, Zhao Lai, Yidong Chen, Yong Liu, Xin Zhang, Xiao-Dong Li
Immune Sensing of Aeroallergen-Associated Double-Stranded RNA Triggers an IFN Response and Modulates Type 2 Lung Inflammation. Journal of immunology (Baltimore, Md. : 1950) 203 (9) (2019)
Jun Liu, Ming Gao, Michael Nipper, Janice Deng, Francis E Sharkey, Randy L Johnson, Howard C Crawford, Yidong Chen, Pei Wang
Activation of the intrinsic fibroinflammatory program in adult pancreatic acinar cells triggered by Hippo signaling disruption. PLoS biology 17 (9) (2019)
Subbarayalu Panneerdoss, Vijay K Eedunuri, Pooja Yadav, Santosh Timilsina, Subapriya Rajamanickam, Suryavathi Viswanadhapalli, Nourhan Abdelfattah, Benjamin C Onyeagucha, Xiadong Cui, Zhao Lai, Tabrez A Mohammad, Yogesh K Gupta, Tim Hui-Ming Huang, Yufei Huang, Yidong Chen, Manjeet K Rao
Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression. Science advances 4 (10) (2018)

Yidong Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yidong Chen